Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of obesity. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://jayasazg005356.blogsidea.com/45664933/semaglutide-a-potential-solution-for-metabolic-disorders